#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Epstein-Barr virus infection Malignant melanoma Burkitt's lymphoma refractory Liver transplant rejection Desmoplastic small round cell tumour Medulloblastoma Soft tissue sarcoma Hypersomnia Superficial vein thrombosis Astrocytoma malignant Liposarcoma recurrent Multifocal motor neuropathy Congenital hypotransferrinaemia Cervix carcinoma Biotinidase deficiency More trials…

    Learn about Rare Diseases

    Wolfram syndrome – Diagnostics Inclusion body myositis – Trials in Disease Familial amyotrophic lateral sclerosis – Basic Information Gaucher’s disease type III – Life with Disease Myelodysplastic syndrome with excess blasts – Treatment Fragile X syndrome – Trials in Disease Activated PI3 kinase delta syndrome Mitochondrial myopathy – Diagnostics Chronic granulomatous disease Angiosarcoma metastatic – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Azelastine Hydrochloride Dydrogesterone Tafasitamab SEVABERTINIB Izaflortaucipir (18F) E2814 CAL101 Rbl027.2 Disodium Levofolinate Ads-015 Levodropropizine Glycerol F770/05 Staphylococcus Aureus DROSPIRENONE Toldc Alnuctamab Divarasib Cln-081 Trandolapril More therapies…

    Learn about Your Condition

    Psychogenic seizure Pyrexia Testicular germ cell cancer Mental disorder Herpes simplex reactivation Aplastic anaemia Pleomorphic leiomyosarcoma Herpes simplex meningitis Head injury Lichenoid keratosis Immunodeficiency congenital Genital herpes simplex Herpes simplex Atopic keratoconjunctivitis Renal cancer metastatic More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Apixaban for Preventing Stroke in Patients with Atrial Fibrillation and Stage 5 Chronic Kidney Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • End stage renal disease
    • Atrial fibrillation
    • Chronic kidney disease
    Investigated Drugs:
    • Apixaban
    Finland France Iceland The Netherlands Norway Poland +1

  • Study on the Safety and Effectiveness of Contezolid Acefosamil, Contezolid, and Linezolid for Adults with Moderate or Severe Diabetic Foot Infections

    Recruiting

    3 1 1
    Investigated Diseases:
    • Diabetic foot infection
    Investigated Drugs:
    • Contezolid
    • Sodium O-Acetyl-(R)-Isoxazol-3-Yl((2-Oxo-3-(2,3,5-Trifluoro-4-(4-Oxo-3,4-Dihydropyridin-1(2H)-Yl)Phenyl)Oxazolidin-5-Yl)Methyl)Phosphoramidate
    • Aztreonam
    Bulgaria Croatia Czechia Estonia France Greece +9

  • Study on Oxygen Therapy and Drug Combination for Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Air, Medicinal
    • Fenoterol Hydrobromide
    • Ipratropium Bromide
    Denmark

  • Study on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Favezelimab
    • Lenvatinib
    • Olaparib
    Austria Belgium Czechia Denmark Estonia Finland +15

  • Comparing Spironolactone and Eplerenone for Patients with Heart Failure and Reduced Ejection Fraction

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac failure
    Investigated Drugs:
    • Eplerenone
    • Spironolactone
    Denmark

  • Study on the Effects of THC 2% Oil for Patients with Chronic Neuropathic Pain

    Recruiting

    2 1
    Investigated Diseases:
    • Neuralgia
    Investigated Drugs:
    • Dronabinol
    The Netherlands
Previous Page
1 … 574 575 576 577 578 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!